Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-based Neurointerventional Procedures
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2019
Price : $35 *
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 08 Jan 2018 Status changed from not yet recruiting to recruiting.
- 13 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 14 Nov 2017.
- 01 Nov 2017 New trial record